Treatment of Malignant Glaucoma by Anterior Vitrectomy From Two Different Approaches
Sponsor
Wenzhou Medical University (Other)
Overall Status
Completed
CT.gov ID
NCT04172857
Collaborator
(none)
9
45
Study Details
Study Description
Brief Summary
To compare the surgical outcomes of treating phacoemulsification with intraocular lens implantation combined with goniosynechialysis (Phaco-IOL-GSL) associated malignant glaucoma (MG), using different incision sites in anterior vitrectomy combined with hyaloidotomy, zonulectomy, and iridectomy (VHZI).
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
9 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Treatment of Malignant Glaucoma Secondary to Cataract Surgery Combined With Goniosynechialysis by Anterior Vitrectomy From Two Different Approaches
Actual Study Start Date
:
May 1, 2015
Actual Primary Completion Date
:
Jan 20, 2019
Actual Study Completion Date
:
Jan 30, 2019
Outcome Measures
Primary Outcome Measures
- Relapse of MG [follow up: 3 to 31 months]
MG relapse after the anterior vitrectomy combined with hyaloidotomy, zonulectomy, and iridectomy (VHZI).
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- MG was diagnosed based on the presence of a central and peripheral shallow anterior chamber with normal or elevated intraocular pressure (IOP).
Exclusion Criteria:
- The diagnosis was made only after confirming the absence of choroidal detachment or hemorrhage and posterior segment mass lesion, using B-scan ultrasonography or ophthalmoscopy
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Wenzhou Medical University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
yin ying zhao,
Researcher；clinical research center,
Wenzhou Medical University
ClinicalTrials.gov Identifier:
NCT04172857
Other Study ID Numbers:
- QZB-MG
First Posted:
Nov 21, 2019
Last Update Posted:
Nov 21, 2019
Last Verified:
Nov 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: